跳至主要内容
临床试验/NCT00086749
NCT00086749已完成不适用

A Prospective Study Of The Effect Of Tamoxifen On Breast Density In Premenopausal Women

Northwestern University1 个研究点 分布在 1 个国家目标入组 53 人开始时间: 2003年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
53
试验地点
1

研究概览

简要总结

RATIONALE: High estrogen levels may be associated with dense breast tissue and an increased risk of developing breast cancer. Tamoxifen may be effective in reducing breast density by decreasing estrogen levels.

PURPOSE: This phase I trial is studying how well tamoxifen works in reducing breast density in premenopausal women with breast cancer or at high risk of developing breast cancer.

详细描述

OBJECTIVES:

Primary

  • Determine whether breast density, as measured by digital mammography, decreases in premenopausal women receiving tamoxifen for breast cancer or for breast cancer risk reduction.
  • Determine whether breast density, as determined by a trained mammographer, decreases in patients treated with this drug.
  • Correlate tamoxifen-induced symptoms in estrogen target tissue with change in salivary steroids in patients treated with this drug.

Secondary

  • Determine the effect of this drug on salivary steroids in regularly cycling and amenorrheic patients.
  • Correlate changes in breast density with tamoxifen-induced alterations in sex steroid levels, as measured in the saliva, of patients treated with this drug.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验